Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MAI-001 by Nanjing Minova Pharmaceutical Technology for Depression: Likelihood of Approval
MAI-001 is under clinical development by Nanjing Minova Pharmaceutical Technology and currently in Phase I for Depression. According to GlobalData,...